{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0001837",
      "entity_text" : "epithelial to mesenchymal transition",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:TGFB",
      "entity_text" : "TGF-beta",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Decrease of TGF-beta level in tumor tissue may be the reason of decreased epithelial to mesenchymal transition (EMT) process observed in tumor tissue of mice treated with both compounds combined, as TGF-beta is one of the most important molecules involved in EMT process XREF_BIBR.",
  "reading_complete" : "2020-08-03T12:46:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T12:43:58Z",
  "trigger" : "decreased",
  "evidence" : [ "TGF-beta level in tumor tissue may be the reason of decreased epithelial to mesenchymal transition" ],
  "pmc_id" : "6587338",
  "score" : 0
}